Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
AMARIN SP ADR (NQ: AMRN)
+0.00 (0.00%)
at
1.080
163,140 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 1.130
Bid (Size) 0.9400 (700)
Ask (Size) 2000.00 (100)
Prev. Close 1.080
Today's Range 1.060 - 1.200
52wk Range 0.4600 - 2.250
Shares Outstanding 27,046,716
Morningstar Profile
View Full Profile
AMARIN SP ADR
The Company is engaged in the research, development and commercialization of novel drugs for cardiovascular disease.
Healthcare
Drug Manufacturers - Other
Exchange Traded NQ
Market Cap 29.21M
Related Companies LID BOMSF BDMS SNSS
Featured News
Read More
Amarin To Present at the 12th Annual BIO CEO & Investor Conference
Feb 02, 2010
from PRNewsWire News Releases
Amarin Provides 2009 Year-End Review to Shareholders
Jan 28, 2010
New investors and experienced new team focused on driving Phase 3 clinical development of AMR101 for cardiovascular diseases Read More
from PRNewsWire News Releases
Featured News
Read More
Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease
Jan 11, 2010
from PRNewsWire News Releases
Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia
Jul 22, 2008
from PRNewsWire News Releases
Amarin - Notice of Annual General Meeting
Jul 08, 2008
from PRNewsWire News Releases
Amarin Announces Completion of the First Tranche of $60 Million Private Placement
May 22, 2008
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA